NCT03215940View on ClinicalTrials.gov

Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
Chronic Pain, Widespread
Interventions
DRUG

Delta-9-Tetrahydrocannabinol

An oral dose of Delta-9-Tetrahydrocannabinol (THC) will be given once a day for five day with pain ratings taken before and after each dose every day.

DRUG

Cannabidiol

An oral dose of Cannabidiol (CBD) will be given once a day for five day with pain ratings taken before and after each dose every day.

DRUG

Placebos

An oral placebo will be given once a day for five day with pain ratings taken before and after each dose every day.

Trial Locations (1)

84108

University Of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT03215940 - Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC) | Biotech Hunter | Biotech Hunter